Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease

BackgroundWe determined the effects of roxadustat on the values of anemia, iron metabolism, renal function, proteinuria, and lipid metabolism and identified the associated factors of the change in hemoglobin levels after roxadustat administration in non-dialysis chronic kidney disease (CKD) patients...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Keiji Hirai, Shohei Kaneko, Saori Minato, Katsunori Yanai, Momoko Hirata, Taisuke Kitano, Kiyonori Ito, Yuichiro Ueda, Susumu Ookawara, Yoshiyuki Morishita
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Subjects:	roxadustat anemia cholesterol triglyceride chronic kidney disease erythropoiesis-stimulating agent
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1071342/full